Semaglutide A New Treatment Option for Type 2 Diabetes
Semaglutide is a medication that has been recently approved by the FDA for the treatment of type 2 diabetes. It belongs to a class of medications known as GLP-1 receptor agonists, which work by mimicking the effects of the hormone GLP-1 in the body. GLP-1 is normally released by the